Canada's Replicor announces potential new drug against H5N1 bird flu (AFP via Yahoo! News)
mtippett | November 2, 2005 at 02:52 pmby
370 views | 0 Recommendations | 0 comments
Canadian pharmaceutical firm Replicor has discovered a compound to treat influenza infections that could potentially be used to fight the deadly H5N1 bird flu, the company's chief executive officer told AFP.